References
- OECD.Stat. Health expenditure and financing. Organisation For Economic Co-Operation & Development; 2022 [cited 2022 Nov 10]. Available from: https://stats.oecd.org/Index.aspx?DataSetCode=SHA
- OECD.Stat. Health status. Organisation for Economic Co-operation & Development; 2022 [cited 2022 Nov 10]. Available from: https://stats.oecd.org/Index.aspx?DataSetCode=HEALTH_STAT
- Osborn R, Squires D, Doty MM, et al. In new survey of eleven countries, US adults still struggle with access to and affordability of health care. Health Aff (Millwood). 2016;35(12):2327–2336. doi: 10.1377/hlthaff.2016.1088
- Tikkanen R, Abrams MK. US health care from a global perspective, 2019: higher spending, worse outcomes. The Commonwealth Fund; 2020 [cited 2022 Nov 10]. Available from: https://www.commonwealthfund.org/publications/issue-briefs/2020/jan/us-health-care-global-perspective-2019
- Layton TJ, Ryan AM. Higher incentive payments in Medicare Advantage’s pay-for-performance program did not improve quality but did increase plan offerings. Health Serv Res. 2015;50(6):1810–1828. doi: 10.1111/1475-6773.12409
- Konetzka RT, Grabowski DC, Perraillon MC, et al. Nursing home 5-star rating system exacerbates disparities in quality, by payer source. Health Aff (Millwood). 2015;34(5):819–827. doi: 10.1377/hlthaff.2014.1084
- Shah S, Sun E. Rating the Medicare Advantage star ratings - improving the status quo. Health Affairs Forefront; 2021 [cited 2022 Nov 10]. Available from: https://www.healthaffairs.org/do/10.1377/forefront.20210128.803030/
- 2015 CMS Medicare Advantage star ratings overview and analysis. Alliance Of Community Health Plans; 2014 [cited 2022 Nov 10]. Available from: https://achp.org/wp-content/uploads/2015_ACHP_Star_Ratings_Overview_Web.pdf
- Grzeskowiak D, Zenner P. Medicare Advantage star ratings: Basics and best practices. 2017 [cited 2022 Nov 10]. Available from: https://www.milliman.com/en/insight/medicare-advantage-star-ratings-basics-and-best-practices
- Part C and D Performance Data. Centers for Medicare & Medicaid Services. 2022 [cited 2022 Nov 10]. Available from: https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovGenIn/PerformanceData
- Evaluation of the Medicare quality bonus payment demonstration. L&M Policy Research LLC;2016 [cited 2022Nov 10]. Available from: https://innovation.cms.gov/files/reports/maqbpdemonstration-finalevalrpt.pdf
- Berenson RA, Garrett B, Shartzer. A Understanding Medicare Advantage payment. Urban Institute; 2022 [cited 2022 Nov 10]. Available from: https://www.urban.org/sites/default/files/2022-09/Understanding%20Medicare%20Advantage%20Payment.pdf
- 5-Star Plan Ratings. Centers for Medicare & Medicaid Services; 2011 [cited 2023 Jun 6]. Available from: https://www.cms.gov/files/document/5-starplan2011v508pdf
- Medicare program; changes to the Medicare Advantage and the Medicare prescription drug benefit programs for contract year 2013 and other changes. Centers for Medicare & Medicaid Services; 2012 [cited 2023 Jun 6]. Available from: https://www.federalregister.gov/documents/2012/04/12/2012-8071/medicare-program-changes-to-the-medicare-advantage-and-the-medicare-prescription-drug-benefit
- Schmittdiel JA, Raebel MA, Dyer W, et al. Medicare STAR excludes diabetes patients with poor CVD risk factor control. Am J Manag Care. 2014;20(12):e573–e581.
- Tsang CCS, Wan JY, Chisholm-Burns MA, et al. Racial/Ethnic disparities in measure calculations for Part D star ratings among Medicare beneficiaries with diabetes, hypertension, and/or hyperlipidemia. Res Social Adm Pharm. 2020;17(8):1469–1477. doi: 10.1016/j.sapharm.2020.11.002
- Browning J, Tsang CCS, Wan JY, et al. Racial and ethnic disparities associated with the measure for drug-drug interactions among Medicare beneficiaries. J Am Pharm Assoc (2003). 2022;62(1):142–149. doi: 10.1016/j.japh.2021.08.023
- Chisholm-Burns MA, Spivey CA, Tsang CCS, et al. Racial and ethnic disparities due to Medicare Part D star ratings criteria among kidney transplant patients with diabetes, hypertension, and/or dyslipidemia. J Manag Care Spec Pharm. 2022;28(6):688–699. doi: 10.18553/jmcp.2022.28.6.688
- Zhu Y, Chen Y, Crimmins EM, et al. Sex, race, and age differences in prevalence of dementia in Medicare claims and survey data. J Gerontol B Psychol Sci Soc Sci. 2021;76(3):596–606. doi: 10.1093/geronb/gbaa083
- Gaugler J, James B, Johnson T, et al. 2022 Alzheimer’s disease facts and figures. Alzheimers Dement. 2022;18(4):700–789. doi:10.1002/alz.12638
- Dong X, Tsang CCS, Browning JA, et al. Solving racial/ethnic disparities associated with Medicare Part D star ratings. Curr Med Res Opin. 2023;39(7):963–971. doi:10.1080/03007995.2023.2217654
- Meghani SH, Gallagher RM. Disparity vs inequity: toward reconceptualization of pain treatment disparities. Pain Med. 2008;9(5):613–623. doi: 10.1111/j.1526-4637.2007.00344.x
- Data file search. Research Data Assistance Center; 2022 [cited 2022 Nov 10]. Available from: https://resdac.org/cms-data?tid_1%5B%5D=1
- Area Health Resources Files. Health Resources & Services Administration. 2022 [cited 2022 Nov 10]. Available from: https://data.hrsa.gov/topics/health-workforce/ahrf
- CCW chronic condition algorithms. Centers for Medicare & Medicaid Services Chronic Conditions Data Warehouse; 2022 [cited 2022 Nov 10]. Available from: https://www2.ccwdata.org/web/guest/condition-categories-chronic
- Lee E, Gatz M, Tseng C, et al. Evaluation of Medicare claims data as a tool to identify dementia. J Alzheimers Dis. 2019;67(2):769–778. doi: 10.3233/JAD-181005
- Announcement of calendar year (CY) 2020 Medicare Advantage capitation rates and Medicare Advantage and Part D payment policies and final call letter. Centers for Medicare & Medicaid Services; 2019 [cited2023 Jun 6]. Available from: https://www.cms.gov/Medicare/Health-Plans/MedicareAdvtgSpecRateStats/Downloads/Announcement2020.pdf
- Jarrín OF, Nyandege AN, Grafova IB, et al. Validity of race and ethnicity codes in Medicare administrative data compared with gold-standard self-reported race collected during routine home health care visits. Med Care. 2020;58(1):e1–e8. doi: 10.1097/MLR.0000000000001216
- Gelberg L, Andersen RM, Leake BD. The Behavioral Model for Vulnerable Populations: application to medical care use and outcomes for homeless people. Health Serv Res. 2000;34(6):1273–1302.
- Medicare managed care manual: chapter 7-risk adjustment. Centers for Medicare & Medicaid Services; [cited 2022 Nov 10]. Available from: https://www.cms.gov/regulations-and-guidance/guidance/manuals/downloads/mc86c07.pdf
- Escarce JJ, Kapur K. Racial and ethnic differences in public and private medical care expenditures among aged Medicare beneficiaries. Milbank Q. 2003;81(2):249–275. doi: 10.1111/1468-0009.t01-1-00053
- Chronic conditions among Medicare beneficiaries. Centers for Medicare & Medicaid Services; [cited 2022 Nov 10]. Available from: https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/chronic-conditions/downloads/2012chartbook.pdf
- Brayne C, Gao L, Matthews F. Challenges in the epidemiological investigation of the relationships between physical activity, obesity, diabetes, dementia and depression. Neurobiol Aging. 2005;26(1):6–10. doi: 10.1016/j.neurobiolaging.2005.09.030
- Akomolafe A, Beiser A, Meigs JB, et al. Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study. Arch Neurol. 2006;63(11):1551–1555. doi: 10.1001/archneur.63.11.1551
- Carty CL, Noonan C, Muller C, et al. Risk factors for Alzheimer’s disease and related dementia diagnoses in American Indians. Ethn Dis. 2020;30(4):671–680. doi: 10.18865/ed.30.4.671
- Tsang CCS, Browning J, Todor L, et al. Factors associated with medication nonadherence among Medicare low-income subsidy beneficiaries with diabetes, hypertension, and/or heart failure. J Manag Care Spec Pharm. 2021;27(8):971–981. doi: 10.18553/jmcp.2021.27.8.971
- Jackson SL, Nair PR, Chang A, et al. Antihypertensive and statin medication adherence among Medicare beneficiaries. Am J Prev Med. 2022;63(3):313–323. doi: 10.1016/j.amepre.2022.02.019
- Zhang Y, Flory JH, Bao Y. Chronic medication nonadherence and potentially preventable healthcare utilization and spending among Medicare patients. J Gen Intern Med. 2022;37(14):3645–3652. doi: 10.1007/s11606-021-07334-y
- Qiao Y, Tsang CCS, Hohmeier KC, et al. Association between medication adherence and healthcare costs among patients receiving the low-income subsidy. Value Health. 2020;23(9):1210–1217. doi: 10.1016/j.jval.2020.06.005
- Categorical adjustment index (CAI) methodology supplement. Centers for Medicare & Medicaid Services; [cited 2022 Nov 10]. Available from: https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovGenIn/Downloads/Supplement-for-Categorical-Adjustment-Index-.pdf
- Smaje A, Weston-Clark M, Raj R, et al. Factors associated with medication adherence in older patients: A systematic review. Aging Med (Milton). 2018;1(3):254–266. doi: 10.1002/agm2.12045
- Briesacher BA, Gurwitz JH, Soumerai SB. Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med. 2007;22(6):864–871. doi: 10.1007/s11606-007-0180-x
- Desai V, Nau D, Conklin M, et al. Impact of environmental factors on differences in quality of medication use: an insight for the Medicare star rating system. J Manag Care Spec Pharm. 2016;22(7):779–786. doi: 10.18553/jmcp.2016.22.7.779
- Dawkins B, Renwick C, Ensor T, et al. What factors affect patients’ ability to access healthcare? An overview of systematic reviews. Trop Med Int Health. 2021;26(10):1177–1188. doi: 10.1111/tmi.13651
- Dalton AR, Alshamsan R, Majeed A, et al. Exclusion of patients from quality measurement of diabetes care in the UK pay‐for‐performance programme. Diabet Med. 2011;28(5):525–531. doi: 10.1111/j.1464-5491.2011.03251.x
- Byrd L, Fletcher A, Menifield C. Disparities in health care: minority elders at risk. ABNF J. 2007;18(2):51–55.